Register for the upcoming 2027 Change Provider Trainings

Join our Provider Relations team members for the virtual provider collaboration session(s). Register Now

Show More

Commercial Migrated Medical Policy

View all Commercial Migrated Medical Policies ›    Learn More About Member Migration ›

ClonoSEQ® Testing for the Assessment of Measurable Residual Disease (MRD)

Policy ID: GT88
Section: Genetic testing
Effective Date: 7/1/2026

Download policy PDF